Literature DB >> 20660764

Promotion of direct reprogramming by transformation-deficient Myc.

Masato Nakagawa1, Nanako Takizawa, Megumi Narita, Tomoko Ichisaka, Shinya Yamanaka.   

Abstract

Induced pluripotent stem cells (iPSCs) are generated from mouse and human fibroblasts by the introduction of three transcription factors: Oct3/4, Sox2, and Klf4. The proto-oncogene product c-Myc markedly promotes iPSC generation, but also increases tumor formation in iPSC-derived chimeric mice. We report that the promotion of iPSC generation by Myc is independent of its transformation property. We found that another Myc family member, L-Myc, as well as c-Myc mutants (W136E and dN2), all of which have little transformation activity, promoted human iPSC generation more efficiently and specifically compared with WT c-Myc. In mice, L-Myc promoted germline transmission, but not tumor formation, in the iPSC-derived chimeric mice. These data demonstrate that different functional moieties of the Myc proto-oncogene products are involved in the transformation and promotion of directed reprogramming.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660764      PMCID: PMC2922531          DOI: 10.1073/pnas.1009374107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Functional analysis of the N-terminal domain of the Myc oncoprotein.

Authors:  Sara K Oster; Daniel Y L Mao; James Kennedy; Linda Z Penn
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

2.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation.

Authors:  B A Malynn; I M de Alboran; R C O'Hagan; R Bronson; L Davidson; R A DePinho; F W Alt
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Reversal of human cellular senescence: roles of the p53 and p16 pathways.

Authors:  Christian M Beauséjour; Ana Krtolica; Francesco Galimi; Masashi Narita; Scott W Lowe; Paul Yaswen; Judith Campisi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

4.  Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.

Authors:  Paul Maddison; Alison Thorpe; Paul Silcocks; John F R Robertson; Caroline J Chapman
Journal:  Lung Cancer       Date:  2010-04-03       Impact factor: 5.705

Review 5.  The myc oncogene: its role in transformation and differentiation.

Authors:  M D Cole
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

6.  Negative regulation of the mammalian UV response by Myc through association with Miz-1.

Authors:  Steffi Herold; Michael Wanzel; Vincent Beuger; Carsten Frohme; Dorothee Beul; Tomi Hillukkala; Juhani Syvaoja; Hans-Peter Saluz; Frank Haenel; Martin Eilers
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

7.  N-myc can cooperate with ras to transform normal cells in culture.

Authors:  G D Yancopoulos; P D Nisen; A Tesfaye; N E Kohl; M P Goldfarb; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

9.  Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture.

Authors:  M Schwab; H E Varmus; J M Bishop
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

10.  L-myc cooperates with ras to transform primary rat embryo fibroblasts.

Authors:  M J Birrer; S Segal; J S DeGreve; F Kaye; E A Sausville; J D Minna
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

View more
  167 in total

1.  Progress in breast cancer research.

Authors:  Kornelia Polyak; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

2.  Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells.

Authors:  Falk Hertwig; Katharina Meyer; Sebastian Braun; Sara Ek; Rainer Spang; Cosima V Pfenninger; Isabella Artner; Gaëlle Prost; Xinbin Chen; Jaclyn A Biegel; Alexander R Judkins; Elisabet Englund; Ulrike A Nuber
Journal:  Cancer Res       Date:  2012-06-20       Impact factor: 12.701

Review 3.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 4.  Towards the generation of patient-specific patches for cardiac repair.

Authors:  Giancarlo Forte; Stefania Pagliari; Francesca Pagliari; Mitsuhiro Ebara; Paolo Di Nardo; Takao Aoyagi
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

5.  Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.

Authors:  Wentao Hu; Yongpei He; Yongjie Xiong; Hong Lu; Hong Chen; Limin Hou; Zhandong Qiu; Yu Fang; Suming Zhang
Journal:  Mol Neurobiol       Date:  2015-02-10       Impact factor: 5.590

Review 6.  The role of FOXO1 in β-cell failure and type 2 diabetes mellitus.

Authors:  Tadahiro Kitamura
Journal:  Nat Rev Endocrinol       Date:  2013-08-20       Impact factor: 43.330

7.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

8.  SEASTAR: systematic evaluation of alternative transcription start sites in RNA.

Authors:  Zhiyi Qin; Peter Stoilov; Xuegong Zhang; Yi Xing
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

9.  Direct conversion of human fibroblasts into functional osteoblasts by defined factors.

Authors:  Kenta Yamamoto; Tsunao Kishida; Yoshiki Sato; Keisuke Nishioka; Akika Ejima; Hiroyoshi Fujiwara; Toshikazu Kubo; Toshiro Yamamoto; Narisato Kanamura; Osam Mazda
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.